Your browser doesn't support javascript.
loading
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
Jarius, Sven; Ruprecht, Klemens; Kleiter, Ingo; Borisow, Nadja; Asgari, Nasrin; Pitarokoili, Kalliopi; Pache, Florence; Stich, Oliver; Beume, Lena-Alexandra; Hümmert, Martin W; Trebst, Corinna; Ringelstein, Marius; Aktas, Orhan; Winkelmann, Alexander; Buttmann, Mathias; Schwarz, Alexander; Zimmermann, Hanna; Brandt, Alexander U; Franciotta, Diego; Capobianco, Marco; Kuchling, Joseph; Haas, Jürgen; Korporal-Kuhnke, Mirjam; Lillevang, Soeren Thue; Fechner, Kai; Schanda, Kathrin; Paul, Friedemann; Wildemann, Brigitte; Reindl, Markus.
Afiliação
  • Jarius S; Molecular Neuroimmunology Group, Otto Meyerhof Center, Department of Neurology, University Hospital Heidelberg, Im Neuenheimer Feld 350, 69120, Heidelberg, Germany. sven.jarius@med.uni-heidelberg.de.
  • Ruprecht K; Department of Neurology, Charité-University Medicine Berlin, Berlin, Germany.
  • Kleiter I; Department of Neurology, Ruhr University Bochum, Bochum, Germany.
  • Borisow N; NeuroCure Clinical Research Center and Clinical and Experimental Multiple Sclerosis Research Center, Department of Neurology, Charité University Medicine, Berlin, Germany.
  • Asgari N; Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine, Charité University Medicine Berlin, Berlin, Germany.
  • Pitarokoili K; Department of Neurology and Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark.
  • Pache F; Department of Neurology, Ruhr University Bochum, Bochum, Germany.
  • Stich O; NeuroCure Clinical Research Center and Clinical and Experimental Multiple Sclerosis Research Center, Department of Neurology, Charité University Medicine, Berlin, Germany.
  • Beume LA; Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine, Charité University Medicine Berlin, Berlin, Germany.
  • Hümmert MW; Department of Neurology, Albert Ludwigs University, Freiburg, Germany.
  • Trebst C; Department of Neurology, Albert Ludwigs University, Freiburg, Germany.
  • Ringelstein M; Department of Neurology, Hannover Medical School, Hannover, Germany.
  • Aktas O; Department of Neurology, Hannover Medical School, Hannover, Germany.
  • Winkelmann A; Department of Neurology, Heinrich Heine University, Düsseldorf, Germany.
  • Buttmann M; Department of Neurology, Heinrich Heine University, Düsseldorf, Germany.
  • Schwarz A; Department of Neurology, University of Rostock, Rostock, Germany.
  • Zimmermann H; Department of Neurology, Julius Maximilians University, Würzburg, Germany.
  • Brandt AU; Molecular Neuroimmunology Group, Otto Meyerhof Center, Department of Neurology, University Hospital Heidelberg, Im Neuenheimer Feld 350, 69120, Heidelberg, Germany.
  • Franciotta D; Department of Neurology, Charité-University Medicine Berlin, Berlin, Germany.
  • Capobianco M; Department of Neurology, Charité-University Medicine Berlin, Berlin, Germany.
  • Kuchling J; IRCCS, C. Mondino National Neurological Institute, Pavia, Italy.
  • Haas J; Centro di Riferimento Regionale SM, Azienda Ospedaliero Universitaria San Luigi Gonzaga, Orbassano, Italy.
  • Korporal-Kuhnke M; Department of Neurology, Charité-University Medicine Berlin, Berlin, Germany.
  • Lillevang ST; Molecular Neuroimmunology Group, Otto Meyerhof Center, Department of Neurology, University Hospital Heidelberg, Im Neuenheimer Feld 350, 69120, Heidelberg, Germany.
  • Fechner K; Molecular Neuroimmunology Group, Otto Meyerhof Center, Department of Neurology, University Hospital Heidelberg, Im Neuenheimer Feld 350, 69120, Heidelberg, Germany.
  • Schanda K; Department of Clinical Immunology, Odense University Hospital, Odense, Denmark.
  • Paul F; Institute of Experimental Immunology, affiliated to Euroimmun AG, Lübeck, Germany.
  • Wildemann B; Clinical Department of Neurology, Medical University Innsbruck, Innsbruck, Austria.
  • Reindl M; NeuroCure Clinical Research Center and Clinical and Experimental Multiple Sclerosis Research Center, Department of Neurology, Charité University Medicine, Berlin, Germany.
J Neuroinflammation ; 13(1): 279, 2016 09 26.
Article em En | MEDLINE | ID: mdl-27788675
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Autoanticorpos / Neuromielite Óptica / Aquaporina 4 / Glicoproteína Mielina-Oligodendrócito / Mielite Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: J Neuroinflammation Assunto da revista: NEUROLOGIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Autoanticorpos / Neuromielite Óptica / Aquaporina 4 / Glicoproteína Mielina-Oligodendrócito / Mielite Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: J Neuroinflammation Assunto da revista: NEUROLOGIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Alemanha